Delivery Order SPE2DX22D0089-SPE2D825F2C59

Award Date 6/9/25
Potential Completion Date 6/10/25
Potential Value $30K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $851,380.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed price pricing type, and an ultimate completion date of July 17, 2023. The contract provides for the delivery of a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications...
This federal contract award, valued at $827,657.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and the ultimate completion date is May 22, 2024. The contract provides for the delivery of a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications across...
This federal contract award is a Delivery Order valued at $1,068.84 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of a range of pharmaceutical products and medical supplies, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,056.32 firm fixed-price delivery order contract is for the supply of various pharmaceutical and medical products, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and antibiotics. The contract has no set-aside designation, indicating open competition. This...
This federal contract award is a Delivery Order valued at $52,958.15 and awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the provision of a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications across multiple therapeutic domains such as diabetes treatments, neurological medications, pain management pharmaceuticals, hormone...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is a delivery order with a firm fixed price ceiling value of $2,917.65 and an ultimate completion date of June 2, 2025. The contract provides for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic...
This federal contract award, valued at $695,515.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the provision of various pharmaceutical products and medical supplies to support military healthcare programs. The contract is not set aside and allows for the delivery of a wide range of medications across multiple therapeutic categories, including diabetes treatments, neurological...
This federal contract award, valued at $927,982.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, without any set-aside designation, indicating open competition. The contract covers the supply of a wide range of pharmaceutical products and medical supplies, including medications across multiple therapeutic areas such as diabetes,...
This federal contract award, valued at $893,428.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, supporting the Medical Supply Chain program within the Defense agency. The contract covers a wide range of pharmaceutical and medical products, including medications across various therapeutic areas such as diabetes, neurology, pain...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,258.90 firm fixed-price delivery order is for the supply of various pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes treatments, neurological medications, pain management pharmaceuticals, hormone treatments, and antibiotics. The contract is...
  • SPE2DX22D0089
    Indefinite Delivery Contract
  • SPE2DX22D0089-SPE2D825F2C59
    Delivery Order

This federal contract award is a Delivery Order valued at $30,176.64 issued to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA), with the ultimate completion date of June 10, 2025. The contract is for the provision of a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications across therapeutic areas such as diabetes, neurology, pain management, and antibiotics. This award is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle for the DLA, U.S. Coast Guard, and other government agencies through December 2026. The contract does not have a set-aside designation, indicating open competition.

Generated 9/8/25, 9:52 AM